More Blood Pressure Meds Recalled Due to Carcinogen

FRIDAY, Dec. 7, 2018 — Over the past few months, numerous recalls of the popular heart drug valsartan have already occurred. Now, generics maker Mylan Pharmaceuticals is adding more products to the list.
The recall involves 104 lots of three…
Source: Topamax